Labocanna

Labocanna FCF Growth

The Year-over-Year Free Cash Flow Growth of Labocanna (LCN.WA) as of Oct 20, 2026 is 12.86 %. In the previous year, Year-over-Year Free Cash Flow Growth was 43.05 % — a change of -70.13% (lower).

FCF Growth

12.86 %

YoY

-70.13%

Last updated:

Year-over-Year Free Cash Flow Growth of Labocanna is 2025 12.86 % . Year-over-Year Free Cash Flow Growth of Labocanna was 2024 43.05 % . It decreases by -70.13% lower compared to the previous year.

The Labocanna FCF Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Growth
Date
FCF Growth
Jan 1, 2017
-1,266.67 PLN
Jan 1, 2018
63.81 PLN
Jan 1, 2019
107.89 PLN
Jan 1, 2020
-100.00 PLN
Jan 1, 2022
77.52 PLN
Jan 1, 2023
-57.36 PLN
Jan 1, 2024
43.05 PLN
Jan 1, 2025
12.86 PLN
The Labocanna FCF Growth history
YEARFCF GrowthYoY
12.86 %-70.13%
43.05 %-175.06%
-57.36 %-173.99%
77.52 %-177.52%
-100.00 %-192.68%
107.89 %+69.09%
63.81 %-105.04%
-1,266.67 %-796.67%
181.82 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Labocanna Stock analysis

What does Labocanna do? Labocanna SA is a pharmaceutical company based in Koszalin, Poland, operating within the Health Care sector. The company's primary focus is on the hemp business, as indicated by its operational description. It completed its initial public offering (IPO) on July 4, 2011, marking its entry into the public market. Labocanna SA is listed under the ticker symbol LCN.WA and holds the ISIN code PLCCTLS00017. The company's headquarters are located in Koszalin, a city in the West Pomeranian Voivodeship (Woj. Zachodniopomorskie) of Poland. Its official website is https://labocanna.pl/, which serves as a primary source of information about its operations and offerings. The company operates within the pharmaceutical industry, though specific details about its products, services, or market position are not provided in the available information. Labocanna SA's activities are centered around the hemp sector, which may include the development, production, or distribution of hemp-related products, though the exact nature of these activities remains unspecified. The company's public listing and headquarters location are key identifiers for its operational and financial profile. No additional details regarding founding year, key personnel, acquisitions, or financial figures are included in the provided data. Labocanna is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Labocanna stock

Year-over-Year Free Cash Flow Growth of Labocanna is 12.86 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Free Cash Flow Growth Labocanna since 2006 – with annual values, charts, and detailed analysis.

FCF growth measures the percentage change in free cash flow. Growing FCF indicates improving cash generation capability.

To evaluate Year-over-Year Free Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Free Cash Flow Growth.

Year-over-Year Free Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Free Cash Flow Growth's Labocanna historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Labocanna

All Key Metrics — Labocanna